Drug stocks edge higher; Pozen rockets

) rocketed on news that the Food and Drug Administration has approved its migraine headache medication Treximet. The drug is a follow-on product to GlaxoSmithKline plc’s

Posted in Forex and stock market |

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.